𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase-II-study of fotemustine, cisplatin and high-dose tamoxifen in metastatic malignant melanoma

✍ Scribed by Semb, K.A.; Aamdal, S.; Bohmann, T.; Lucas, C.; Gerard, B.

Book ID
122008291
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
161 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase I and pharmacokinetic study of h
A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma
✍ Edward F. McClay; Mary-Eileen T. McClay; Jeffery A. Jones; Paul J. Winski; Rando πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r

Phase II study of high-dose tamoxifen (N
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma
✍ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas